Skip to main content

Echo Assessment of AR



Imaging Assessment of Aortic Regurgitation (AR)

--

Introduction


Aortic regurgitation (AR) is characterized by diastolic backflow of blood from the aorta into the left ventricle (LV). Imaging plays a central role in diagnosis, quantification of severity, mechanism identification, and timing of intervention.



---


1. Transthoracic Echocardiography (TTE) – First-Line Modality


Primary tool for evaluation.


A. Mechanism of AR


Leaflet pathology: prolapse, perforation, restriction


Aortic root disease: dilation, dissection


Vegetations (infective endocarditis)



B. Qualitative Parameters


Color Doppler jet width and extent


Jet direction (eccentric vs central)


Dense continuous-wave (CW) Doppler signal



C. Semi-Quantitative Parameters


Vena contracta width


Mild: <0.3 cm


Severe: ≥0.6 cm



Pressure half-time (PHT)


Severe AR: <200 ms




D. Quantitative Parameters


Regurgitant volume ≥60 mL → Severe


Regurgitant fraction ≥50% → Severe


Effective regurgitant orifice area (EROA) ≥0.3 cm² → Severe



E. LV Assessment


LV dilation (eccentric hypertrophy)


LV systolic function (EF)


Serial measurements crucial for timing surgery




---


2. Transesophageal Echocardiography (TEE)


Indicated when TTE is suboptimal or detailed anatomy is needed.


Superior for:


Valve morphology


Endocarditis complications (abscess, perforation)


Prosthetic valve assessment



Essential in intraoperative guidance




---


3. Cardiac Magnetic Resonance (CMR)


Gold standard for quantification of AR severity and LV volumes.


Advantages:


Accurate regurgitant volume and fraction


Precise LV size and function (no geometric assumptions)


Useful in eccentric jets where echo is limited



Severe AR (CMR):


Regurgitant fraction ≥50%




---


4. Computed Tomography (CT)


Adjunct modality, especially for aortic pathology.


Uses:


Aortic root and ascending aorta measurement


Detection of aneurysm or dissection


Pre-surgical planning (e.g., valve-sparing surgery, TAVI)




---


5. Cardiac Catheterization


Now rarely used for AR quantification.


Indications:


When non-invasive imaging is inconclusive


Coronary angiography before surgery


Aortography (historical grading I–IV)




---


6. Integrated Approach to Severity


No single parameter is sufficient—use a multiparametric approach:


Combine:


Color Doppler findings


Vena contracta


Quantitative Doppler (EROA, regurgitant volume)


LV size and function


CMR when discordant





---


7. Role of Imaging in Follow-Up


Mild AR: every 3–5 years


Moderate AR: every 1–2 years


Severe AR: every 6–12 months



Key focus:


LV end-diastolic and end-systolic dimensions


EF decline (<55% concerning)


Symptom correlation




---


8. Key Surgical Triggers (Imaging-Based)


Symptomatic severe AR


Asymptomatic with:


LVEF ≤55%


LVESD >50 mm (or indexed >25 mm/m²)


Progressive LV dilation





---


Conclusion


Imaging in AR is multimodality and dynamic, with echocardiography as the cornerstone and CMR providing gold-standard quantification. Serial imaging is essential to guide optimal timing of intervention and prevent irreversible LV dysfunction.


Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...